What is an Anti-GAD test?
The Anti-GAD test is a blood test that detects autoantibodies against glutamic acid decarboxylase (GAD), an enzyme found in several tissues, including the pancreatic beta cells that produce insulin.
Anti-GAD antibodies are markers of an autoimmune response in which the immune system mistakenly targets the body's own cells.
Anti-GAD antibodies are most commonly associated with type 1 diabetes, including autoimmune diabetes that develops in adulthood. They can also be detected in some people with latent autoimmune diabetes in adults (LADA) and, less commonly, in certain neurological autoimmune disorders.
What is the Anti-GAD test used for?
The test may be used to:
Support the diagnosis of autoimmune type 1 diabetes
Help distinguish autoimmune diabetes from type 2 diabetes
Investigate diabetes diagnosed in adulthood when the type of diabetes is uncertain
Support evaluation for latent autoimmune diabetes in adults (LADA)
Assess autoimmune beta-cell destruction in selected patients
Investigate certain neurological autoimmune conditions when clinically indicated
Anti-GAD is often interpreted together with other diabetes-related autoantibodies, such as:
Insulin autoantibodies (IAA)
IA-2 antibodies
Zinc transporter 8 (ZnT8) antibodies
Islet cell antibodies (ICA)
Why do I need an Anti-GAD test?
Your healthcare provider may request this test if it is unclear whether diabetes is autoimmune or non-autoimmune.
It may be particularly useful when:
Diabetes develops at a relatively young age
Diabetes occurs in an adult who does not have typical features of type 2 diabetes
Blood glucose is difficult to control despite treatment
There is a personal or family history of autoimmune disease
The healthcare provider suspects LADA
There is uncertainty about the appropriate classification of diabetes
Anti-GAD testing may also be requested when evaluating certain neurological symptoms that may be associated with anti-GAD autoimmunity.
What happens during the test?
A small blood sample is collected from a vein in your arm.
The serum is tested using an immunological method to measure GAD autoantibodies.
Depending on the laboratory's assay, the result may be reported as Positive/Negative, Detected/Not detected, or as a numerical antibody concentration with a laboratory-specific cutoff.
Will I need to do anything to prepare?
Usually, no fasting or special preparation is required.
Tell your healthcare provider about any known diabetes, autoimmune disease, medications, and previous antibody or diabetes-related test results.
Are there any risks?
The test involves a routine blood collection. You may experience minor discomfort, bruising, or tenderness at the collection site.
Serious complications are very uncommon.
What do the results mean?
Positive result
A positive Anti-GAD result means that antibodies against glutamic acid decarboxylase were detected.
In a patient with diabetes, a positive result supports the possibility of autoimmune diabetes, including type 1 diabetes or LADA.
The strength of the antibody result and the patient's clinical features can provide additional information, but a positive Anti-GAD result alone does not establish the complete type or severity of diabetes.
In adults with diabetes, Anti-GAD positivity may suggest a slower autoimmune process consistent with LADA rather than typical type 2 diabetes.
Anti-GAD antibodies may also be detected in certain autoimmune neurological disorders, so the clinical interpretation depends on why the test was ordered.
Negative result
A negative Anti-GAD result means that GAD autoantibodies were not detected at the level measurable by the assay.
This may make autoimmune diabetes less likely, but does not completely exclude it.
Some people with type 1 diabetes do not have detectable GAD antibodies. Other diabetes-related autoantibodies, including IA-2 and ZnT8 antibodies, may be positive instead.
If the clinical suspicion remains high, your healthcare provider may recommend testing for additional autoantibodies and assessing C-peptide and blood glucose to help evaluate insulin production.
Important note about the results
Anti-GAD is an important marker of autoimmune diabetes, but it should not be interpreted as a stand-alone diagnostic test.
A positive result supports an autoimmune process affecting pancreatic beta cells, particularly when diabetes is present. However, the result should be interpreted together with blood glucose, HbA1c, C-peptide, clinical presentation, age at onset, body characteristics, treatment requirements, and other diabetes-related autoantibodies when appropriate.
Anti-GAD antibodies may also occur in people without diabetes and are associated with certain neurological autoimmune disorders. Therefore, the significance of a positive result depends strongly on the clinical context.
The antibody concentration and positive cutoff vary between assays and manufacturers. Results should always be interpreted according to the laboratory's validated reference range and the specific testing method used.
Prefer to talk to someone first? Contact us to book.
